Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.48 and traded as low as $2.25. Oramed Pharmaceuticals shares last traded at $2.34, with a volume of 44,022 shares. Oramed Pharmaceuticals […]
Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Declines By 25.9% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a hold rating to a sell rating in a report published on Monday morning. A number of other research analysts also recently weighed in on ORMP. Canaccord Genuity Group downgraded Oramed Pharmaceuticals from a buy rating to a hold rating and dropped their price […]
Strs Ohio cut its stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) by 41.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,400 shares of the biotechnology company’s stock after selling 3,900 shares during the quarter. […]